Table 13:
Summary Estimates of All-Cause and Prostate-Specific Mortality From Systematic Reviews
| All-Cause Mortality | Prostate Cancer Mortality | |||||
|---|---|---|---|---|---|---|
| Author, Year | RCTs (Men), n | RR (95% CI) | P Value | RCTs (Men), n | RR (95% CI) | P Value |
| Djulbegovic et al, 2010 (81) | 4 (256,019) | 0.99 (0.97–1.02) | 0.44 | 5 (302,500) | 0.88 (0.71–1.09) | 0.25 |
| Ilic et al, 2013 (82) | 5 (341,342) | 1.00 (0.96–1.03) | 0.84 | 5 (341,342) | 1.00 (0.86–1.17) | 0.99 |
| Lee et al, 2013 (83) | 5 (266,750) | 0.99 (0.98–1.01) | 0.50 | 4 (313,236) | 0.93 (0.81–1.07) | 0.31 |
| Lumen et al, 2011 (84) | 4 (206,393) | 0.90 (0.75–1.08) | 0.32 | 7 (318,631) | 0.88 (0.72–1.06) | 0.18 |
Abbreviations: CI, confidence interval; n, number; RCT, randomized control trial; RR, relative risk.